iSpecimen Launches AI-Powered Tool for Biospecimen Marketplace
iSpecimen Inc. introduced an AI-powered Inventory Agent to accelerate biospecimen request matching on its marketplace platform. The tool uses large language models to process research requests and identify available inventory matches.
Shares of iSpecimen Inc. (NASDAQ: ISPC) are surging after the company announced the launch of a new AI-powered tool designed to improve the efficiency of its biospecimen marketplace platform. The technology-driven company, which connects life science researchers with a global network of biospecimen suppliers, introduced its new AI-powered Inventory Agent following Thursday's closing bell, helping drive strong momentum in the stock Friday morning. Shares of ISPC are up 52.5% to $0.3417 in Friday trading as investors react to the company's latest AI-driven platform innovation.
iSpecimen's newly launched AI agent is designed to accelerate the process of reviewing incoming biospecimen requests and matching them with available inventory across its supplier network. Developed internally, the tool analyzes research request criteria and identifies potential matches from biospecimen inventories, allowing the company's team to respond to researchers more quickly and with greater accuracy.
The AI-powered Inventory Agent is embedded directly into the company's redesigned marketplace platform and utilizes large language models (LLMs) to process requests through an intuitive conversational interface. Researchers can submit requests in plain language, and the system automatically extracts key criteria such as disease conditions, sample types, and diagnostic test requirements. It then dynamically searches configured inventory sources to surface potential matches.
Results generated by the system are ranked by relevance and delivered alongside supporting details, giving the iSpecimen team the information needed to quickly evaluate and confirm suitable biospecimens. By automating the initial review and matching workflow, the technology helps reduce manual workload while maintaining expert oversight to ensure compliance and quality standards remain intact.
The CEO stated the new AI-driven capability marks an important step forward for the company's mission of optimizing the biospecimen marketplace. By improving how researchers connect with available biological samples, the platform aims to accelerate scientific discovery while benefiting both suppliers and research organizations.
The Inventory Agent is expected to be the first of several AI-powered tools planned for the platform. Future capabilities under development include automated monitoring and validation of regulatory submissions, expanded automation for high-compliance workflows, and intelligent lead qualification and outreach management. These enhancements are designed to further streamline the process of sourcing human biospecimens and reduce friction for researchers seeking critical samples.
iSpecimen's marketplace platform plays an important role in connecting life science researchers with human biological samples used in medical research and diagnostics development. By leveraging advanced technology to simplify access to these resources, the company aims to help researchers move more efficiently from hypothesis to discovery.